Walking away from radiation fatigue? small study tests exercise after breast cancer
NCT ID NCT06070155
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether mild to moderate aerobic exercise, done three times a week for three weeks, could improve quality of life and blood levels of zinc, copper, and iron in 28 post-menopausal women who had radiotherapy for breast cancer. The goal was to see if a simple exercise routine could help recovery after treatment.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- aerobic exercise
- What this could lead to
- If it works, this could point toward a simple, drug-free way to improve well-being after breast cancer treatment.
- What could go wrong
- This is a very small, completed study with only 28 participants, so results may not apply to everyone. Exercise may not significantly change trace element levels or quality of life.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
28 people
The number who actually took part.
- Started
-
Oct 2023
- Finished
-
Jan 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
50 to 60 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * All postmenopausal women with breast cancer and received radiotherapy immediately at the end of radiotherapy or max six months to one year in each group. after clinically diagnosed by Oncologist with breast cancer Stage I and II . * Their ages will range from 50-60 years old. * Good general Health (ECOG performance status 0-1). * Voluntary acceptance of participation in the study. Exclusion Criteria: * Systematic chronic diseases (respiratory diseases, cardiovascular diseases…etc) * Cognitive dysfunction as well as neuromuscular or musculoskeletal impairment or disease affecting postural control or motion pattern. * Professional athletes.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Breast cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Tarek Hussein
Cairo, Cairo Governorate, 11931, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a faster radiation course match the standard one after breast reconstruction?
- Can High-Risk breast cancer patients skip an extra radiation boost?
- Radioactive probe lights up CD73 on breast tumors in PET scans
- Can time with horses help cancer patients feel better?
- Can an oral drug replace injections for advanced breast cancer?
- Can a common steroid shield breast cancer patients from a dangerous drug side effect?